|
⚲
|
| Keyboard |
| Chan Barbara Y
✚
|
|
|---|---|
| CIK # | 0001676343 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001676343] | |
| 4 | [0001676343] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Omega Therapeutics Inc | |
| Chan Barbara Y | |
| Novelion Therapeutics Inc | |
| Aegerion Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Novelion Therapeutics Inc NVLN
Common Shares
|
2019-09-24 | Tax withheld | 1,688 | $0.76 | 1,283 |
|
Novelion Therapeutics Inc NVLN
Common Shares
|
2019-03-15 | Tax withheld | 996 | $1.26 | 1,255 |
|
Novelion Therapeutics Inc NVLN
Common Shares
|
2018-12-06 | Tax withheld | 3,313 | $1.28 | 4,241 |
|
Novelion Therapeutics Inc NVLN
Stock Option (Right to Buy) · derivative
|
2018-08-22 | Grant | 50,000 | $0.00 | |
|
Novelion Therapeutics Inc NVLN
Common Shares
|
2018-03-15 | Grant | 8,600 | $0.00 | |
|
Novelion Therapeutics Inc NVLN
Stock Option (Right to Buy) · derivative
|
2018-03-15 | Grant | 40,000 | $0.00 | |
|
Novelion Therapeutics Inc NVLN
Common Shares
|
2017-12-06 | Tax withheld | 1,216 | $3.33 | 4,049 |
|
Novelion Therapeutics Inc NVLN
Stock Option (Right to Buy) · derivative
|
2017-05-01 | Grant | 20,000 | $0.00 | |
|
Novelion Therapeutics Inc NVLN
Restricted Stock Units · derivative
|
2016-12-06 | Grant | 75,000 | $0.00 | |
|
Aegerion Pharmaceuticals Inc AEGR
Stock Option (Right to Buy) · derivative
|
2016-11-29 | Disposed to issuer | 26,000 | ||
|
Novelion Therapeutics Inc NVLN
Stock Option (Right to Buy) · derivative
|
2016-11-29 | Grant | 26,665 | ||
|
Aegerion Pharmaceuticals Inc AEGR
Stock Option (right to buy) · derivative
|
2016-07-01 | Grant | 26,000 | $0.00 |